Genedrive rockets as it says coronavirus test could be available in eight weeks
The diagnostics firm is also working on a second product that will allow coronavirus testing outside of hospitals in places such as clinics and ICUs
Company
genedrive PLC
LON:GDR
genedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms.
240 stories · page 5 of 12
Genedrive frustrated by slow take-up of diagnostic kit
The kit performed exceptionally well in the field as demonstrated in HCV study data and AIHL CE marking studies’.
Archive
Proactive news snapshot: Rockfire Resources, Genedrive, Collagen Solutions, Power Metal Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Genedrive gains as it reports high clinical accuracy for infant hearing loss test
The kit is designed to screen babies for a genetic mutation, MT-RNR1, which if present, can cause lifelong deafness if they are prescribed with the antibiotic gentamicin
Genedrive gets CE mark for baby deafness diagnostic test
David Budd, genedrive’s chief executive, said: "CE marking of our RNR1 test allows for the next phase, with implementation evaluation by our NHS partners in Manchester and Liverpool."
Genedrive gets approval to trial baby deafness test in NHS hospitals
Genedrive says its test delivers a genetic result in less than 30 minutes
Genedrive expects to make good progress with diagnostics pipeline
The update was provided alongside full-year results from the group, which has developed rapid assays for Hepatitis-C (HCV) and pathogen detection
Archive
Proactive news snapshot: Kavango Resources, OptiBiotix Health, Cello Health...
A glance at some of the day's highlights from the Proactive Investors newswire
Genedrive zips higher as chairman snaps up £10,000 worth of shares
Ian Gilham bought 51,250 shares at 19p apiece on Tuesday
Archive
Proactive news snapshot: ClearStar, Ceres Power, Concepta, IQ-AI …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Begbies Traynor firing on all cylinders
A look at the day's major movers, including Knights Group, CyanConnode, Vela, Primorus, Two Shields, Anglo African Agriculture, Panthera Resources and Elegant Hotels
Genedrive ‘confident’ of WHO approval for hepatitis C test by autumn
There have been some delays to the WHO’s qualification trial owing to a lack of low viral load samples for analysis, but bosses remain confident of approval and expect a result by this autumn
Peel Hunt resumes coverage of Genedrive with a ‘buy’ rating and 60p price target after recent results
The Peel Hunt analysts noted stronger traction than expected with the US Department of Defence (DoD), with the group having received a second order of the DoD in January
Archive
Aukett Swanke subsides after downbeat AGM statement
A look at the day's major movers, including Ironveld, Brave Bison, Pebble Beach, Zanaga, Debenhams, 7digital and Diurnal
Archive
Proactive news snapshot: Europa Metals, Ceres Power, Arix Bioscience, Hurricane Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Genedrive optimistic about some near-term progress on its Genedrive HCV ID registrations
"We continue to execute our strategy of market entry for our Hepatitis C point of need molecular test and development of both our tuberculosis and antibiotic-induced hearing loss assays," said David Budd, the CEO of genedrive
Archive
Blue chips to swerve Thursday’s Brexit fall-out, small caps will be in spotlight
IGas and Gulf Keystone are on the agenda, meanwhile Brexit will likely be a talking point for Eddie Stobart Logistics.
Archive
Brexit date arrives but March 29 to be a damp squib although parliamentary vote might not be
Aside from the latest instalment of the Brexit saga, the week ahead will bring updates from housebuilder Bellway, tobacco firm Imperial Brands, and soft drinks group Fevertree
Archive
Proactive news snapshot: EQTEC , Itaconix, Mirada …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
CloudCall's new user intake rate accelerates
A look at the day's major movers, including Elegant Hotels, Mears Group, Spire Healthcare, 7digital and Mirada